![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
May 25, 2022
BURLINGTON, Ontario – May 25, 2022: Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is pleased to announce the closing of the first tranche of a Private Placement. The tranche consists of 506,157 Common Share...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
May 12, 2022
BURLINGTON, Ontario – May 12, 2022: Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, provides the following update regarding the signing of a number of strategically significant agreements with Oakland Health Limited (operating as “RD...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
April 26, 2022
BURLINGTON, Ontario – April 26, 2022- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform and Skycare Compounding Labs (“Skycare”) a leader in compounding services for the Canadian prescription market, today announce the...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
March 7, 2022
BURLINGTON, Ontario – March 8, 2022- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company focused on health and wellness leveraging an innovative, proprietary oral delivery medication and nutraceutical platform, along with their UK and European partner RD Therapeutics, proudly...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
February 10, 2022
BURLINGTON, Ontario – February 10, 2022- Rapid Dose Therapeutics Corp. (“RDT” or the“Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation today announced a management change in the Company. The Board of Directors provided notice on February 9, 2022 of its intention...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
January 5, 2022
BURLINGTON, Ontario – January 5, 2022- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is pleased to announce another significant addition to the Company’s advisory board with the appointment of Dr. Michael Glogauer. Dr....
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
December 22, 2021
BURLINGTON, Ontario – December 22, 2021- Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) and McMaster University (“McMaster”) are pleased to announce that the ongoing development of an orally delivered vaccine candidate for COVID-19 has received the final instalment of the Collaborative...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
December 15, 2021
Additions to support immediate commercialization efforts for the Company’s COVID-19 vaccine candidate BURLINGTON, Ontario – December 15, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is pleased to announce a significant addition to...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
December 9, 2021
BURLINGTON, Ontario – December 9, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, entered into an agreement on Friday, November 26, 2021 with Oakland Health Limited (“Oakland Health” operating as “RD Therapeutics”) to...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
November 30, 2021
BURLINGTON, Ontario – November 30, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, has entered into a strategic business development agreement with AB Strategic Ventures (“ABSV”) with the purpose of supporting relationship building...